Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Scientists reverse a sensory impairment in mice with autism

Scientists reverse a sensory impairment in mice with autism

“We’re trying to identify early brain processes that will impact behaviors in children when they are older,” said Anubhuti Goel, a postdoctoral researcher in neurology at UCLA and first author of the study. Credit: University of California, Los Angeles

Using a genetic technique that allows certain neurons in the brain to be switched on or off, UCLA scientists reversed a sensory impairment in mice with symptoms of autism, enabling them to learn a sensory task as quickly as healthy mice.

The findings, which appear in the journal Nature Neuroscience, offer an intriguing glimpse of a potential strategy to help people with autism make sense of what their eyes see.

In humans, the ability to perceive visual information is critical to learning of all kinds, including the interpretation of social cues. In children with autism, avoiding eye contact and struggling to understand people’s feelings may be rooted in how their brains process visual information.

“The focus in autism has been trying to tackle social impairment. But if there is a deficit in learning due to being unable to process certain kinds of sensory input, it affects your development,” said Anubhuti Goel, a postdoctoral researcher in neurology at UCLA and the study’s first author. “We’re trying to identify early brain processes that will impact behaviors in children when they are older.”

For this experiment, Goel and colleagues at UCLA used mice with a similar mutation in the FMR1 gene as humans with fragile X syndrome, a genetic condition that is the most commonly inherited cause of autism in humans. Mice with the mutation share a number of autism symptoms with people with fragile X syndrome, including anxiety, reduced social interaction and an overreaction to sensory stimuli such as texture and sound.

The researchers trained mice on a visual discrimination task, where the goal for the mice was to lick a drop of water in response to a specific visual cue on a screen. A pattern of parallel, black-and-white lines slanting a certain way signified the presence of a water drop; slanted a different way, there was no water drop. If the mice took too long to decide, the water drop disappeared—vacuumed up by the scientists.

On average, normal control mice mastered the strategy for getting water in about three days, whereas the mice with autism typically required five to nine days.

By recording brain activity in the mice, researchers found that the visual cortex of the fragile X syndrome mice, or FXS mice, had fewer and less finely tuned neurons called pyramidal cells. These excitatory neurons—the “gas pedal” in the brain—found in rodents, monkeys and humans, are responsible for perceiving the orientation of visual information, for example, the angle of the lines in the experiment. In addition, researchers found reduced activity in parvalbumin neurons, which are inhibitory neurons—the “brake pedal”—that work in concert with pyramidal cells, kicking them into gear and “tuning” them to respond to specific, or more general, bits of visual information.

The researchers wondered if they could prod those parvalbumin cells into working harder, which would in turn stimulate the pyramidal cells.

They targeted the parvalbumin cells with a genetic technique called DREADD, which stands for Designer Receptors Exclusively Activated by Designer Drugs. They injected the fragile X syndrome mice with a virus carrying the genes for these special designer receptors; once inside the mouse’s parvalbumin cells, the virus generates the DREADD receptors. Next, a drug administered intravenously reached those receptors and activated the parvalbumin cells.

Once the fragile X syndrome mice with the designer receptors received the drug, they could learn the visual discrimination task as quickly as their healthy counterparts did. The impact of the designer drug lasted for three to four hours.

“These experiments shed light on the brain circuit problems behind those difficulties in autism, and hint at directions we can pursue for treatment in the future,” Goel said.

Goel’s next step will be figuring out what happens in the visual discrimination task with sensory distractors, such as flashing lights or loud sounds. Many autistic children and adults are unable to tune out such distractors, which could contribute to poor performance in school and anxiety in social settings. Fragile X syndrome mice, too, have sensory over-reactivity, which could impede their learning.


Explore further:
Drug may reverse imbalance linked to autism symptoms

More information:
Anubhuti Goel et al. Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible, Nature Neuroscience (2018). DOI: 10.1038/s41593-018-0231-0

Journal reference:
Nature Neuroscience

Provided by:
University of California, Los Angeles

Tagged with:

About author

Related Articles